{
    "2021-01-27": [
        [
            {
                "time": "",
                "original_text": "新冠疫苗接种稳步推进，这些业绩预增股可提前布局丨牛熊眼",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "接种",
                        "稳步推进",
                        "业绩预增股",
                        "提前布局"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}